BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Diabetes mellitus
,
Liver
,
Personalized medicine
,
Fluoxetine
,
rs3825942
,
KLK3
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Retinoic acid receptor responder protein 2
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Adrenal gland cortex
Duodenum
Adrenal gland
Adipose tissue subcutaneous
Ovary
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Williams syndrome
Klinefelter's syndrome, XXY
Lyme disease
Hypercalciuria
Zika virus disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
AT 7519
flavopiridol
BMS 387032
pronethalol
casiopeina II-glycine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
LIX1L
CHD8
SMPDL3B
CDH3
RARRES2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Irradiated human fibroblasts compared to cells at each phase of cell cycle
Liver Pharmacology and Xenobiotic Response Repertoire
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
Cutaneous melanoma after treatment with tumor necrosis factor (TNF) and melphalan
Dermal fibroblasts treated with conditioned media from breast cancer cell cultures
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Retinoic acid receptor responder protein 2
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in…
Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Ind…
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS
Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2)
Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ